Novo Nordisk Goes ‘Full-Speed Ahead’ Towards Once-Weekly Basal Insulin

Readouts to all six ONWARDS trials to come in 2022, Development Head Says

The attraction of a once-weekly injected basal insulin would be high, Martin Lange says • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D